Frank Jiang, Founder and CEO speaking at Phar-East 2018, Singapore, 28February-2 March 2018

5 minutes with Frank Jiang, founder of CStone, a Chinese immunotherapy biotech company

Emily Event News Leave a Comment

Immunotherapy advancement is a global trend, but it’s also greatly impacting the future of pharma in Asia. To prepare for this week’s feature, we interviewed Dr Frank Jiang, CEO and founder of CStone, a Chinese biotech company focused on addressing the most important patient needs in China and beyond. With immuno-oncology as CStone’s core therapeutic focus, the company strives to lead Chinese …

Image taken from http://www.cfr.org/china/chinese-pharma-global-health-game-changer/p36365

Regaining the confidence of Chinese biomanufacturing industry

Emily Event News Leave a Comment

Similar to other developing countries, the quality of Chinese bioproduction is often questioned by international markets due to various outbreak of scandals related to breach of quality protocols in production process. We invited Dr Amy Que, Vice President of Quality Control of Innovent Biologics, one of the leading innovation-driven biotech companies emphasizing on quality production to speak at the 10th BioPharma …

pharma-manufacturing_645x400

Finding global GMP-certified CMOs in China

Emily Event News Leave a Comment

In-house biomanufacturing is costly. Besides the heavy infrastructure investment required, the need to efficiently manage talent, capacity, financial resources and quality often encourages pharma companies to consider outsourcing as an alternative. However,  despite the growing number of CMO and CDMO within China,  the availability of CMO providing high quality yet affordable services is lagging way behind the amount of demand within …